Wegovy vs Mounjaro: Complete Switching Guide With All Doses
Can I Switch To Wegovy From Mounjaro? Understanding Your Complete Dose Options
When patients ask "can I switch to Wegovy from Mounjaro", the answer depends on individual clinical circumstances and prescriber guidance. EverydayMeds stocks the complete Wegovy dose range, ensuring continuity throughout your entire treatment journey from initial 0.25mg through to 2.4mg maintenance dosing. Unlike switching between multiple suppliers, our comprehensive inventory means one clinical relationship supports your long-term weight management goals. Both Wegovy (semaglutide) and Mounjaro (tirzepatide) are prescription-only medicines that work through different mechanisms - Wegovy targets GLP-1 receptors exclusively, while Mounjaro activates both GIP and GLP-1 pathways as a dual agonist.
The switching decision often centres on practical factors including injection frequency, storage requirements, and dose escalation schedules. Our clinical team maintains expertise in both medications, providing seamless transitions when clinically appropriate. Whether you're starting fresh or switching from another treatment, having access to every Wegovy dose eliminates supply chain concerns that can disrupt treatment adherence. This comprehensive approach ensures patients receive consistent pharmaceutical care from a single GPhC-registered provider throughout their weight management journey.
Wegovy Pricing Structure: Every Dose Available With Transparent Costs
Understanding the complete cost of switching from Mounjaro to Wegovy requires transparency across all dose levels. Our Wegovy pricing starts with 0.25mg starter doses at £79.99, progressing through 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), to maintenance 2.4mg at £209.99. New customers apply code FIRST40 at checkout, while returning patients use DOSE25 to access these final prices. Our Getting Started bundles like the Intro Duo (0.25mg & 0.5mg) provide two months' initial treatment for £169.99, ensuring smooth dose escalation without ordering interruptions. The Step-Up bundles accommodate patients wanting longer-term supply security, with the Progress Trio covering weeks 5-16 for £369.99.
For patients reaching maintenance phase, our Ultimate Stability Trio delivers three months of 2.4mg dosing for £649.99, representing the convenience of quarterly ordering rather than monthly supply management. Bundle pricing emphasises supply continuity and delivery convenience rather than purely cost savings. Every order includes next-day cold-chain delivery, maintaining the 2-8°C storage requirements from our GPhC #9012878 registered online pharmacy to your door. This comprehensive pricing structure ensures no surprises when progressing through the complete Wegovy dose escalation protocol.
Clinical Evidence: Can I Switch To Wegovy From Mounjaro Based On Research?
The STEP clinical trial programme provides extensive evidence for Wegovy's effectiveness in weight management when used alongside a reduced-calorie diet and increased physical activity. In clinical trials, patients taking Wegovy achieved an average of approximately clinically studied weight loss at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP 5 trial demonstrated sustained weight management with approximately 15.2% average weight loss maintained at 2 years, supporting long-term treatment approaches.
When considering switching from Mounjaro to Wegovy, it's important to note that direct head-to-head comparisons aren't available due to different trial designs and patient populations. Both medications demonstrated significant weight management benefits in their respective clinical programmes. Your prescriber will evaluate individual factors including treatment response, side effect profile, and practical considerations when determining whether switching from Mounjaro to Wegovy might be clinically appropriate for your specific circumstances.
How Wegovy Works: GLP-1 Mechanism For Patients Switching From Mounjaro
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the natural incretin hormone produced in your intestines after eating. This mechanism differs from Mounjaro's dual GIP/GLP-1 approach, focusing specifically on GLP-1 pathways to reduce appetite and promote satiety. The medication works primarily in your brain's appetite centres, helping you feel fuller after smaller meals and potentially reducing food cravings throughout the day. This once-weekly injection provides sustained GLP-1 activation, supporting consistent appetite regulation between doses. Understanding this focused GLP-1 mechanism helps explain why some patients may respond differently to Wegovy compared to Mounjaro's dual-hormone approach. Your prescriber can evaluate whether this single-pathway mechanism aligns better with your treatment goals and individual response pattern.
Complete Ordering Process: Switching To Wegovy With Full Dose Support
Accessing Wegovy through EverydayMeds begins with our 3-minute online clinical assessment, designed to evaluate your suitability for this prescription-only medicine. Our prescribers review your medical history, current medications, and treatment goals within 3 working days (24 hours with express review), ensuring clinical safety when switching from Mounjaro to Wegovy. Once approved, we dispatch your prescribed dose via next-day delivery using cold-chain transportation to maintain the required 2-8°C storage conditions. Our comprehensive dose availability means your prescriber can select any appropriate starting point without supply constraints affecting clinical decisions. This streamlined process eliminates the complexity of switching between multiple pharmacy providers during dose escalation phases.
Storage Advantages: Why Wegovy May Suit Patients Switching From Mounjaro
One practical advantage when patients switch to Wegovy from Mounjaro involves storage flexibility, particularly for frequent travellers or those with varying daily routines. Wegovy maintains stability for up to 6 weeks at room temperature below 30°C once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. This extended storage window provides greater flexibility for business trips, holidays, or lifestyle situations where consistent refrigeration isn't assured. The FlexTouch pen system offers intuitive dose administration with clear dose counter visibility and audible click confirmation. Dose escalation follows a mandatory 4-week schedule at each level: 0.25mg, 0.5mg, 1mg, 1.7mg, before reaching 2.4mg maintenance dosing. This structured progression allows gradual tolerance development while maximising treatment effectiveness throughout the switching and escalation process.
Why Complete Dose Availability Matters When Switching From Mounjaro To Wegovy
Patients considering the switch from Mounjaro to Wegovy often underestimate the importance of assured dose progression support throughout their treatment journey. Wegovy requires mandatory dose escalation every 4 weeks, and supply interruptions at any level can necessitate restarting from lower doses, effectively resetting treatment progress. Our comprehensive inventory eliminates this risk by maintaining stock across all five dose levels simultaneously. This approach proves particularly valuable for patients in maintenance phases, where 2.4mg availability determines long-term treatment sustainability rather than forcing unwanted switches to alternative medications.
The psychological benefit of dose security shouldn't be underestimated when making treatment transitions. Knowing your pharmacy can support the complete 16-week escalation journey plus ongoing maintenance removes a significant stress factor from weight management treatment. Many patients report that supply uncertainty with previous providers created anxiety about treatment continuity, potentially affecting their commitment to lifestyle changes that complement medication therapy. Our "one pharmacy for your entire treatment" approach specifically addresses these concerns for patients switching between weight management medications.
Making Your Decision: Complete Support For Switching From Mounjaro To Wegovy
Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which medication aligns best with your individual circumstances, treatment history, and weight management goals. The decision to switch involves multiple factors including mechanism of action preferences, storage requirements, injection frequency, and individual response patterns. Our clinical assessment process evaluates these factors comprehensively, ensuring any treatment transition occurs safely and effectively. Ready to explore your options with complete dose availability and expert clinical support? Start your assessment today and discover why thousands of patients trust EverydayMeds for their weight management journey. Use code FIRST40 for new customer pricing, with next-day delivery and ongoing clinical support throughout your treatment. Visit https://everydaymeds.co.uk/collections/wegovy to begin your comprehensive clinical evaluation with our qualified prescribers.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
